Gerald Yakatan
Chief Executive Officer at Societal CDMO San Diego LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| W. Hertz | M | 54 |
GRI Operations, Inc.
 GRI Operations, Inc. BiotechnologyHealth Technology GRI Bio, Inc. develops cell based therapies for fibrotic and autoimmune diseases. Its programs are GRI-0621, GRI-0124, and GRI-0803. The company was founded by Marc Hertz, Vipin Kumar, and Albert Agro and is headquartered in La Jolla, CA. | - |
| Albert Agro | M | 59 |
GRI Operations, Inc.
GRI Operations, Inc. BiotechnologyHealth Technology GRI Bio, Inc. develops cell based therapies for fibrotic and autoimmune diseases. Its programs are GRI-0621, GRI-0124, and GRI-0803. The company was founded by Marc Hertz, Vipin Kumar, and Albert Agro and is headquartered in La Jolla, CA. | - |
| Vipin Kumar | M | - |
GRI Operations, Inc.
GRI Operations, Inc. BiotechnologyHealth Technology GRI Bio, Inc. develops cell based therapies for fibrotic and autoimmune diseases. Its programs are GRI-0621, GRI-0124, and GRI-0803. The company was founded by Marc Hertz, Vipin Kumar, and Albert Agro and is headquartered in La Jolla, CA. | - |
| Sean G. Edwards | M | - |
GRI Operations, Inc.
GRI Operations, Inc. BiotechnologyHealth Technology GRI Bio, Inc. develops cell based therapies for fibrotic and autoimmune diseases. Its programs are GRI-0621, GRI-0124, and GRI-0803. The company was founded by Marc Hertz, Vipin Kumar, and Albert Agro and is headquartered in La Jolla, CA. | 8 years |
| Jie Chen | F | 50 |
Continent Pharmaceutical Inc.
 Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 5 years |
| Ying Luo | M | 58 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 13 years |
| Bing Chen | M | 40 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 5 years |
| Jianyuan Luo | M | 61 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 5 years |
| Song Jiang Ma | M | 68 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 22 years |
| Robert Giannini | M | - |
Societal CDMO San Diego LLC
 Societal CDMO San Diego LLC Pharmaceuticals: MajorHealth Technology Societal CDMO San Diego LLC engages in the development of pharmaceutical product. It specializes in formulation research and development, cGMP (current Good Manufacturing Practices) manufacturing of clinical trial materials and commercial pharmaceutical products, and consulting related to the drug development process. The company was founded by Gerald J. Yakatan in 1996 and is headquartered in San Diego, CA. | 20 years |
| Ruo Yu Chen | F | 54 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 6 years |
| Xiao Xing Jiang | M | 42 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 7 years |
| Brian Connelly | M | - |
IriSys, Inc.
 IriSys, Inc. Pharmaceuticals: MajorHealth Technology IriSys, Inc. operates as an investment holding company with interests in pharmaceuticals. The company was founded was founded by Gerald J. Yakan on December 12, 2001 and is headquartered in San Diego, CA. | - |
| Thomas Eastling | M | 63 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 9 years |
| Weiguo Ye | M | 47 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 8 years |
| Lin Han | M | 52 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 6 years |
| Mingli Zhu | M | 51 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 15 years |
| Zhenhui Chu | M | - |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 12 years |
| Qingmei Zhu | F | - |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 12 years |
| Ling Zhang | M | 52 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 6 years |
| Yanping Ye | M | 41 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 6 years |
| Qijia Liu | M | 43 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | 7 years |
| Po Man Mak | F | 40 |
Continent Pharmaceutical Inc.
Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China. | - |
| Abraham van Wyck | M | - |
GRI Operations, Inc.
GRI Operations, Inc. BiotechnologyHealth Technology GRI Bio, Inc. develops cell based therapies for fibrotic and autoimmune diseases. Its programs are GRI-0621, GRI-0124, and GRI-0803. The company was founded by Marc Hertz, Vipin Kumar, and Albert Agro and is headquartered in La Jolla, CA. | 10 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Gregory P. Hanson | M | 77 | 8 years | |
| Victoria C. Smith | F | 76 |
Tanabe Research Laboratories U.S.A., Inc.
 Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | 6 years |
| David H. Katz | M | - | 10 years | |
| Paul E. Rosenthal | M | - |
University of Florida
| 7 years |
| Dennis Podlesak | M | 66 | 10 years | |
| Charles A. Mathews | M | 86 | - | |
| Fred Janz | M | - |
University of Florida
| 7 years |
| Henry Edwin Mehlman | M | - |
University of Florida
| 6 years |
| Daniel Zimmerman | M | 83 |
University of Florida
| 4 years |
| Robert C. Joyner | M | 76 |
University of Florida
| 7 years |
| Christopher A. White | M | - |
University of Florida
| 7 years |
| Hal Uhrig | M | - |
University of Florida
| 6 years |
| Henry N. Adorno | M | 76 |
University of Florida
| 7 years |
| Anne B. Furr | F | - |
University of Florida
| 5 years |
| Michael Cruse | M | 52 | 10 years | |
| Stephen G. Austin | M | 71 | 9 years | |
| Neal A. Roth | M | 71 |
University of Florida
| 4 years |
| Andrew Josh Markus | M | - |
University of Florida
| 3 years |
| Madaboosi Santanam Ananth | M | 78 |
University of Florida
| 3 years |
| Leslie Molony | M | - |
Tanabe Research Laboratories U.S.A., Inc.
Tanabe Research Laboratories U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Tanabe Research Laboratories U.S.A., Inc. develops pharmaceutical products. The company is based in San Diego, CA. | - |
| Douglas Kanter | M | 71 |
University of Florida
| 4 years |
| Harvey Hoffenberg | M | 72 |
University of Florida
| 4 years |
| Michael R. Band | M | - |
University of Florida
| 4 years |
| Nancy K. Watkin | F | - |
University of Florida
| 4 years |
| Alan S. Trager | M | - |
University of Florida
| 4 years |
| Michael B. Goldberg | M | 77 |
University of Florida
| 4 years |
| Kenneth J. van Ness | M | 71 |
University of Florida
| 4 years |
| Kenneth R. McGurn | M | - |
University of Florida
| 4 years |
| Larry K. Krannich | M | - |
University of Florida
| 3 years |
| Neil Abdollahian | M | 51 | 2 years | |
| Howard Brunt | M | - |
University of Florida
| 4 years |
| Ellen Corenswet | F | - |
University of Florida
| 4 years |
| Carl Robert Morganstein | M | - |
Temple University (Pennsylvania)
| 4 years |
| Steve Davis | M | - |
University of Florida
| 4 years |
| Ron Pecora | M | - |
University of Florida
| 4 years |
| Charlene Fogel | F | - |
Temple University (Pennsylvania)
| 3 years |
| Terry Ernest Burke | M | 79 |
University of Florida
| 3 years |
| Muhammad Ismail | M | - |
University of Florida
| 4 years |
| Corrine Brown | F | 77 |
University of Florida
| 1 years |
| Brian Schiller | M | - | 3 years | |
| Larry R. Freedman | M | 72 |
University of Florida
| 4 years |
| Lemuel Sharp | M | - |
University of Florida
| 4 years |
| Larry Stessel | M | - |
University of Florida
| 4 years |
| Phillip W. Ware | M | 73 |
University of Florida
| 4 years |
| Michael D. Watford | M | 70 |
University of Florida
| 4 years |
| Jagadish C. Sircar | M | 89 | 12 years | |
| Gus Fernandez | M | 67 | - | |
| Lamar Nash | M | 77 |
University of Florida
| 4 years |
| Bowers W. Espy | M | 73 |
University of Florida
| 4 years |
| Michael P. Hill | M | 73 |
University of Florida
| 4 years |
| Drew H. Webb | M | 77 |
University of Florida
| 4 years |
| Steven Kessler | M | 81 |
Temple University (Pennsylvania)
| 4 years |
| Wayne T. Hockmeyer | M | 79 |
University of Florida
| 3 years |
| William F. Bahl | M | 73 |
University of Florida
| 4 years |
| Robert Emanuele | M | 69 | 4 years | |
| James E. Berg | M | 73 | 9 years | |
| John David Hansen | M | 72 | 8 years | |
| Stuart A. Samuels | M | 82 | - | |
| Jonathan Silverstein | M | 57 | 9 years | |
| Tom Curran | M | - |
Temple University (Pennsylvania)
| 4 years |
| James McClave | M | - |
University of Florida
| 3 years |
| Linda C. McGurn | F | - |
University of Florida
| 4 years |
| James T. Medick | M | 77 |
University of Florida
| 4 years |
| Robert Scharar | M | 74 |
University of Florida
| 4 years |
| Fred Ridley | M | 71 |
University of Florida
| 4 years |
| Richard M. Heimann | M | - |
University of Florida
| 4 years |
| John D. Thornby | M | - |
University of Florida
| 4 years |
| Patrick O'Brien | M | - | 2 years | |
| George Lawrence Kirkland | M | 73 |
University of Florida
| 4 years |
| Charles C. Appleby | M | 75 |
University of Florida
| 4 years |
| Robert L. Bryan | M | 72 |
University of Florida
| 4 years |
| Stephen A. Crane | M | - |
University of Florida
| 4 years |
| Robert B. Uhler | M | - |
University of Florida
| 1 years |
| Dick Rice | M | - |
University of Florida
| 4 years |
| Murray M. Spain | M | 80 |
Temple University (Pennsylvania)
| 4 years |
| Jack Azout | M | - |
University of Florida
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 83 | 83.00% |
| China | 17 | 17.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gerald Yakatan
- Personal Network
